BIONDI ANDREA

Role
Former Full Professor  
Email
[email protected]
Room:
  • U06, Floor: 4, Room: 4010B

Publications

  • Bettini, L., Lattuada, M., Silvestri, D., Lo Nigro, L., Bertorello, N., Parasole, R., et al. (2026). INTERIM RESULTS OF THE QUESTIONNAIRE ON PREDISPOSITION TO ACUTE LYMPHOBLASTIC LEUKEMIA IN THE AIEOP-BFM ALL 2017 PROTOCOL. In Abstract book of the XIX Congress of the Italian Society of Experimental Hematology, Florence, 4-6 March 2026 (pp.1-1). Ferrata Storti Foundation [10.3324/haematol.2026.s1.127]. Detail

  • Curto, A., Peccatori, N., Rebellato, S., Rapisarda, R., Bhatia, S., Borkhardt, A., et al. (2026). FLT3 AS A NEW THERAPEUTIC TARGET IN PRECLINICAL MODELS OF PEDIATRIC BCP-ALL WITH PAX5 REARRANGEMENT. In Abstract book of the XIX Congress of the Italian Society of Experimental Hematology, Florence, 4-6 March 2026 (pp.1-1). Ferrata Storti Foundation [10.3324/haematol.2026.s1.23]. Detail

  • Acunzo, D., Bertagna, M., Risca, G., Beneforti, L., Bresolin, S., Galimberti, S., et al. (2026). TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS. In Abstract book of the XIX Congress of the Italian Society of Experimental Hematology, Florence, 4-6 March 2026 (pp.1-1). Ferrata Storti Foundation [10.3324/haematol.2026.s1.108]. Detail

  • Colombo, D., Sala, A., Modola, M., L'Imperio, V., Rambaldi, A., Biondi, A., et al. (2026). Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein–Taybi Syndrome With Combined Rituximab and Eltrombopag. PEDIATRIC BLOOD & CANCER, 73(5 (May 2026)) [10.1002/1545-5017.70172]. Detail

  • Stoppa, M., Pagani Bagliacca, E., Russo, S., Rampoldi, G., Strepparava, M., Balduzzi, A., et al. (2026). Ironic Medications: A Narrative-Based Psycho-Educational Intervention to Explore Patient–Provider Communication in Adolescents With Haematological Cancer. PEDIATRIC BLOOD & CANCER [10.1002/1545-5017.70491]. Detail

Full list

Research projects

Innovative CAR Therapy Platforms (INCAR) - V annualità
Year: 2023
Grantors: FONDAZIONE AIRC
Adoptive Chimeric Antigen Receptor cell therapy for the treatment of patients with Acute Myeloid Leukemia: Development of preclinical models to assess efficacy and safety
Year: 2021
Call: Decreto Direttoriale n.1628 del 16-10-2020 - Bando PRIN 2020
Grantors: M.I.U.R. - MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA
Innovative CAR Therapy Platforms INCAR - IV annualità
Year: 2021
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), CANCER RESEARCH UK, FONDAZIONE AIRC
Innovative CAR Therapy Platforms - INCAR III annualità
Year: 2020
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), CANCER RESEARCH UK, FONDAZIONE AIRC
Innovative CAR Therapy Platforms - INCAR II annualità
Year: 2019
Call: 2017-034 - Accelerator Award
Grantors: FUNDACION CIENTIFICA DE LA ASOCIACION ESPAGNOLA CONTRAL EL CANCER (AECC), FONDAZIONE AIRC, CANCER RESEARCH UK

Awards

Scientific fellowships

  • Fellow - International BFM Study Group, 2016
  • Fellow - European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), 2012
  • Fellow - Associazione Italiana di Ematologia ed Oncologia Pediatrica A.I.E.O.P., 2012
  • Fellow - The European Society for Paediatric Oncology (SIOPE), 2004

Management or corporate responsibility

  • Direttore Scientifico - Fondazione M.Tettamanti M.De Marchi, 2006
  • Direttore Scientifico - Fondazione Monza e Brianza per il Bambino e la sua Mamma - MBBM, 2010

Congresses/Conferences

  • Program chair - Annual Meeting International BFM Study Group(Repubblica Ceca), 2019
  • Program chair - European Hematology Association Paediatric Course, 2017
  • Program chair - Annual Meeting International BFM Study Group, 2017